UA74547C2 - Pharmaceutical composition based on anticholinergic compounds and beta-mimetics and method for its production - Google Patents

Pharmaceutical composition based on anticholinergic compounds and beta-mimetics and method for its production Download PDF

Info

Publication number: UA74547C2
Authority: UA; Ukraine
Prior art keywords: methyl; pharmaceutical composition; optionally; hydroxy; composition according
Prior art date: 1999-05-12

Application number

UA2001128535A

Other languages

English (en)

Ukrainian (uk)

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-12

Filing date

2000-03-05

Publication date

2006-01-16

2000-03-05 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2006-01-16 Publication of UA74547C2 publication Critical patent/UA74547C2/uk

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyrrole Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

UA2001128535A 1999-05-12 2000-03-05 Pharmaceutical composition based on anticholinergic compounds and beta-mimetics and method for its production UA74547C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19921693A DE19921693A1 (de)	1999-05-12	1999-05-12	Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
PCT/EP2000/003943 WO2000069468A1 (fr)	1999-05-12	2000-05-03	Nouvelles compositions medicamenteuses a base de composes a action anticholinergique et de betamimetiques

Publications (1)

Publication Number	Publication Date
UA74547C2 true UA74547C2 (en)	2006-01-16

Family

ID=7907709

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA2001128535A UA74547C2 (en)	1999-05-12	2000-03-05	Pharmaceutical composition based on anticholinergic compounds and beta-mimetics and method for its production

Country Status (41)

Country	Link
US (3)	US6455524B1 (fr)
EP (7)	EP2269648A3 (fr)
JP (5)	JP4612956B2 (fr)
KR (2)	KR100841909B1 (fr)
CN (2)	CN1250290C (fr)
AR (1)	AR023972A1 (fr)
AT (1)	ATE245976T1 (fr)
AU (1)	AU775588B2 (fr)
BG (1)	BG65189B1 (fr)
BR (1)	BR0010498A (fr)
CA (1)	CA2368583C (fr)
CO (1)	CO5140068A1 (fr)
CZ (1)	CZ302328B6 (fr)
DE (2)	DE19921693A1 (fr)
DK (1)	DK1178832T3 (fr)
EA (1)	EA004657B1 (fr)
EE (4)	EE201000020A (fr)
ES (1)	ES2203470T3 (fr)
HK (1)	HK1043064B (fr)
HR (1)	HRP20010828A2 (fr)
HU (1)	HUP0201103A3 (fr)
IL (3)	IL146119A0 (fr)
ME (1)	MEP36608A (fr)
MX (1)	MXPA01011400A (fr)
MY (2)	MY129512A (fr)
NO (2)	NO328423B1 (fr)
NZ (1)	NZ515596A (fr)
PE (1)	PE20010133A1 (fr)
PL (2)	PL199442B1 (fr)
PT (1)	PT1178832E (fr)
RS (2)	RS20090083A (fr)
SA (1)	SA00210064B1 (fr)
SG (4)	SG179293A1 (fr)
SI (1)	SI1178832T1 (fr)
SK (1)	SK287072B6 (fr)
TR (2)	TR200901979T2 (fr)
TW (2)	TWI272106B (fr)
UA (1)	UA74547C2 (fr)
UY (1)	UY26139A1 (fr)
WO (1)	WO2000069468A1 (fr)
ZA (1)	ZA200108942B (fr)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030215396A1 (en) *	1999-09-15	2003-11-20	Boehringer Ingelheim Pharma Kg	Method for the production of propellant gas-free aerosols from aqueous medicament preparations
DE19653969A1 (de) *	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
GB9902689D0 (en) *	1999-02-08	1999-03-31	Novartis Ag	Organic compounds
DE19921693A1 (de) *	1999-05-12	2000-11-16	Boehringer Ingelheim Pharma	Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20100197719A1 (en) *	1999-05-12	2010-08-05	Boehringer Ingelheim Pharma Kg	Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20040002548A1 (en) *	1999-05-12	2004-01-01	Boehringer Ingelheim Pharma Kg	Medicament compositions containing anticholinergically-effective compounds and betamimetics
US7214687B2 (en)	1999-07-14	2007-05-08	Almirall Ag	Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP1326642A2 (fr) *	2000-09-29	2003-07-16	Board of Trustees operating Michigan State University	Preparations pharmaceutiques de catecholamine et procedes
US7776315B2 (en) *	2000-10-31	2010-08-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmaceutical compositions based on anticholinergics and additional active ingredients
DE10206505A1 (de) *	2002-02-16	2003-08-28	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und EGFR-Kinase-Hemmern
US20020137764A1 (en)	2000-10-31	2002-09-26	Karin Drechsel	Inhalable formulation of a solution containing a tiotropium salt
US20020111363A1 (en) *	2000-10-31	2002-08-15	Karin Drechsel	Inhalable formulation of a solution containing a tiotropium salt
US6620438B2 (en) *	2001-03-08	2003-09-16	Boehringer Ingelheim Pharma Kg	Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
US6608054B2 (en) *	2001-03-20	2003-08-19	Boehringer Ingelheim Pharma Kg	Pharmaceutical compositions based on anticholinergics and endothelin antagonists
DE10056104A1 (de) *	2000-11-13	2002-05-23	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
US20020193392A1 (en) *	2000-11-13	2002-12-19	Christel Schmelzer	Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) *	2000-11-28	2010-12-09	Boehringer Ingelheim Pharma Gmbh & Co. Kg.	Pharmaceutical compositions based on anticholingerics and additional active ingredients
US6667344B2 (en) *	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20050070487A1 (en) *	2001-04-24	2005-03-31	Nyce Jonathan W.	Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
DE10126924A1 (de) *	2001-06-01	2002-12-05	Boehringer Ingelheim Pharma	Inhalationskapseln
US20030018019A1 (en) *	2001-06-23	2003-01-23	Boehringer Ingelheim Pharma Kg	Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
EP1416990A1 (fr) *	2001-08-09	2004-05-12	Glaxo Group Limited	Dispositif d'inhalation a composition pharmaceutique
JP2005504076A (ja) *	2001-09-14	2005-02-10	ベーリンガーインゲルハイムファルマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	新規な吸入用医薬組成物
US6919325B2 (en) *	2001-09-14	2005-07-19	Boehringer Ingelheim Pharma Kg	Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7309707B2 (en)	2002-03-20	2007-12-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
DE10212264A1 (de) †	2002-03-20	2003-10-02	Boehringer Ingelheim Pharma	Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7754242B2 (en) *	2002-03-20	2010-07-13	Alkermes, Inc.	Inhalable sustained therapeutic formulations
DE10214263A1 (de) *	2002-03-28	2003-10-16	Boehringer Ingelheim Pharma	HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7244415B2 (en) *	2002-03-28	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations of an anhydrate
KR101007151B1 (ko) *	2002-04-04	2011-01-13	베링거 잉겔하임 파르마 게엠베하 운트 코 카게	흡입용 분말 제형
UA80123C2 (en) *	2002-04-09	2007-08-27	Boehringer Ingelheim Pharma	Inhalation kit comprising inhalable powder of tiotropium
US20030225089A1 (en) *	2002-04-10	2003-12-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
DE10216427A1 (de) *	2002-04-12	2003-10-23	Boehringer Ingelheim Pharma	Arzneimittelkompositionen enthaltend heterocyclische Verbindungen und ein neues Anticholinergikum
US7084153B2 (en) *	2002-04-12	2006-08-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments comprising steroids and a novel anticholinergic
US7417051B2 (en) *	2002-04-12	2008-08-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments comprising betamimetics and a novel anticholinergic
US20040048887A1 (en) *	2002-07-09	2004-03-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
DE10230751A1 (de) *	2002-07-09	2004-01-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
US7250426B2 (en) *	2002-11-29	2007-07-31	Boehringer Ingelheim Pharma Gmbh & Co Kg	Tiotropium-containing pharmaceutical combination for inhalation
UA83813C2 (ru) *	2002-12-20	2008-08-26	Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг	Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола
US20040152720A1 (en) *	2002-12-20	2004-08-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
PE20040950A1 (es)	2003-02-14	2005-01-01	Theravance Inc	DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
JP4767842B2 (ja) *	2003-04-01	2011-09-07	セラヴァンス，インコーポレーテッド	β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物
DE602004021921D1 (de) *	2003-05-28	2009-08-20	Theravance Inc	Azabicycloalkanverbindungen als muscarinrezeptor antagonisten
TW200510298A (en) *	2003-06-13	2005-03-16	Theravance Inc	Substituted pyrrolidine and related compounds
SE526509C2 (sv) *	2003-06-19	2005-09-27	Microdrug Ag	Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
SE527200C2 (sv) *	2003-06-19	2006-01-17	Microdrug Ag	Inhalatoranordning samt kombinerade doser av formaterol och fluticason
SE527189C2 (sv) *	2003-06-19	2006-01-17	Microdrug Ag	Inhalatoranordning samt kombinerade doser för formaterol och ett antikolinergiskt medel
SE527190C2 (sv) *	2003-06-19	2006-01-17	Microdrug Ag	Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid
ES2284025T3 (es) *	2003-07-29	2007-11-01	Boehringer Ingelheim International Gmbh	Medicamentos para inhalar que comprenden betamimeticos y un anticolinergico.
US20050026948A1 (en) *	2003-07-29	2005-02-03	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050026882A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20090317476A1 (en) *	2003-07-31	2009-12-24	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050025718A1 (en) *	2003-07-31	2005-02-03	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050101545A1 (en) *	2003-07-31	2005-05-12	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) *	2003-07-31	2005-02-17	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
DE10345065A1 (de)	2003-09-26	2005-04-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
ES2329586T3 (es) *	2003-11-21	2009-11-27	Theravance, Inc.	Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino.
SE0303570L (sv) *	2003-12-03	2005-06-04	Microdrug Ag	Fukt-känslig medicinsk produkt
ES2309705T3 (es) *	2004-02-06	2008-12-16	MEDA PHARMA GMBH & CO. KG	Nueva combinacion de anticolinergico y beta-mimeticos para el tratamiento de enfermedades respiratorias.
ES2413011T3 (es) *	2004-02-06	2013-07-15	Meda Pharma Gmbh & Co. Kg	Combinación de anticolinérgicos y glucocorticoides para el tratamiento a largo plazo de asma y EPOC
EP1713471B1 (fr) *	2004-02-06	2012-01-18	MEDA Pharma GmbH & Co. KG	Combinaison d'anticholinergiques et d'inhibiteurs de phosphodiesterase type 4 pour le traitement de maladies respiratoires
CA2553369A1 (fr) *	2004-02-20	2005-09-01	Boehringer Ingelheim International Gmbh	Compositions pharmaceutiques a base d'anticholinergiques et de pegsunercept
US20060189524A1 (en) *	2004-02-20	2006-08-24	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions based on anticholinergics and pegsunercept
US20050186175A1 (en) *	2004-02-20	2005-08-25	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins
US7507745B2 (en)	2004-02-20	2009-03-24	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
EP1725525A1 (fr) *	2004-03-11	2006-11-29	Theravance, Inc.	Composes biphenyle convenant en tant qu'antagonistes du recepteur muscarinique
JP2007528418A (ja) *	2004-03-11	2007-10-11	セラヴァンス，インコーポレーテッド	ムスカリンレセプターアンタゴニストとしての有用なジフェニルメチル化合物
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
ES2257152B1 (es) *	2004-05-31	2007-07-01	Laboratorios Almirall S.A.	Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
TW200540154A (en) *	2004-06-10	2005-12-16	Theravance Inc	Crystalline form of a substituted pyrrolidine compound
WO2006023460A2 (fr)	2004-08-16	2006-03-02	Theravance, Inc.	Composes a activite agoniste pour recepteur ?2 adrenergique et antagoniste pour recepteur muscarinique
WO2006023457A1 (fr) *	2004-08-16	2006-03-02	Theravance, Inc.	Composes a activite agoniste pour recepteur ?2 adrenergique et antagoniste pour recepteur muscarinique
EP1863476B1 (fr) *	2005-03-16	2016-02-03	MEDA Pharma GmbH & Co. KG	Combinaison d'anticholinergiques et d'antagonistes de recepteur de leukotriene permettant de traiter les maladies respiratoires
US20060239935A1 (en) *	2005-04-23	2006-10-26	Boehringer Ingelheim International Gmbh	Compositions for inhalation
JP2008538758A (ja) *	2005-04-23	2008-11-06	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物
WO2006117299A2 (fr) *	2005-05-02	2006-11-09	Boehringer Ingelheim International Gmbh	Formes cristallines de bromure de tiotropium
NZ564697A (en) *	2005-06-15	2010-04-30	Boehringer Ingelheim Int	Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
WO2007017437A1 (fr) *	2005-08-06	2007-02-15	Boehringer Ingelheim International Gmbh	Procédé pour le traitement de la dyspnée comprenant l’administration combinée de sels de tiotropium et de sels de salmétérol
TWI274641B (en) *	2005-08-30	2007-03-01	Rexon Ind Corp Ltd	Cutting machine
NZ591969A (en) *	2005-12-21	2012-05-25	Meda Pharma Gmbh & Co Kg	Combination of anticholinergics, glucocorticoids, beta2-adrenoceptor agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases
TW200811105A (en)	2006-04-25	2008-03-01	Theravance Inc	Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
JP2009538361A (ja) *	2006-05-26	2009-11-05	デイ・リミテッド・パートナーシップ	４級アンモニウムムスカリン受容体アンタゴニストの噴霧可能組成物
ES2298049B1 (es) *	2006-07-21	2009-10-20	Laboratorios Almirall S.A.	Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
CA2608561A1 (fr) *	2007-10-29	2009-04-29	Carl Paluszkiewicz	Support d'accessoires de deflecteur pour motocyclette
CA2716936C (fr) *	2008-02-26	2018-06-05	Elevation Pharmaceuticals, Inc.	Procede et systeme permettant de traiter la bronchopneumopathie chronique obstructive au moyen d'administrations d'anticholinergiques par nebulisation
US20100055045A1 (en)	2008-02-26	2010-03-04	William Gerhart	Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
EP2100598A1 (fr)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
EP2100599A1 (fr)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
PL3111927T3 (pl)	2009-05-29	2020-06-29	Pearl Therapeutics, Inc.	Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
JO3510B1 (ar) *	2011-03-04	2020-07-05	Heptares Therapeutics Ltd	استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
EP2510928A1 (fr)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires
ME02297B (me)	2011-06-10	2016-02-20	Chiesi Farm Spa	Jedinjenja koja imaju aktivnost antagonista muskarinskih receptora i agonist beta2 adrenergičnog receptora
BR112013030302B1 (pt)	2011-06-10	2021-08-24	Chiesi Farmaceutici S.P.A.	Composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo
GB201113662D0 (en)	2011-08-08	2011-09-21	Prosonix Ltd	Pharmaceutical compositions
TW201311649A (zh) *	2011-09-05	2013-03-16	Everlight Chem Ind Corp	用於太陽能電池電解液之化合物及其製法、含有該化合物之電解液及太陽能電池
BR112015012730B1 (pt)	2012-12-06	2022-07-05	Chiesi Farmaceutici S.P.A.	Composto, composição farmaceutica, dispositivo, uso de um composto e combinação
AR093832A1 (es)	2012-12-06	2015-06-24	Chiesi Farm Spa	COMPUESTOS CON ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES MUSCARINICOS Y ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENERGICO
SG11201507286QA (en)	2013-03-15	2015-10-29	Pearl Therapeutics Inc	Methods and systems for conditioning of particulate crystalline materials
TWI703138B (zh) *	2015-02-12	2020-09-01	義大利商吉斯藥品公司	具有蕈毒鹼受體拮抗劑及β２腎上腺素受體促效劑活性之化合物
AR104828A1 (es)	2015-06-01	2017-08-16	Chiesi Farm Spa	COMPUESTOS CON ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES MUSCARÍNICOS Y ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENÉRGICO
WO2017093208A1 (fr)	2015-12-03	2017-06-08	Chiesi Farmaceutici S.P.A.	Composés ayant une activité d'antagoniste des récepteurs muscariniques et d'agoniste des récepteurs adrénergiques bêta2
EP3484879B1 (fr)	2016-07-13	2020-12-30	Chiesi Farmaceutici S.p.A.	Composés hydroxyquinoléinoniques ayant une activité antagoniste pour le récepteur muscarinique et une activité agoniste pour le récepteur adrénergique bêta2
US10555903B2 (en)	2016-10-14	2020-02-11	Glenmark Specialty S.A.	Nebulizable compositions of tiotropium and formoterol
RU2722720C1 (ru)	2016-12-14	2020-06-03	Бейджинг Шоубай Фармасьютикэл Ко., Лтд.	Класс бифункциональных соединений со структурой соли четвертичного аммония
KR102547782B1 (ko)	2017-01-31	2023-06-23	알피니티 유에스에이, 인크.	일체형 펌프를 갖는 바이오프로세스 용기
CN117679423A (zh)	2022-09-05	2024-03-12	立生医药(苏州)有限公司	预防或治疗呼吸系统疾病的吸入用药物组合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8613811D0 (en)	1986-06-06	1986-07-09	Phares Pharm Res Nv	Composition & method
JP3042866B2 (ja) *	1989-09-08	2000-05-22	グラクソ・グループ・リミテッド	呼吸疾患治療薬
DE3931041C2 (de)	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE4003270A1 (de) *	1990-02-03	1991-08-08	Boehringer Ingelheim Kg	Neue treibgase und ihre verwendung in arzneimittelzubereitungen
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
US5290539A (en) *	1990-12-21	1994-03-01	Minnesota Mining And Manufacturing Company	Device for delivering an aerosol
EP0504112A3 (en) *	1991-03-14	1993-04-21	Ciba-Geigy Ag	Pharmaceutical aerosol formulations
DE4108393A1 (de)	1991-03-15	1992-09-17	Boehringer Ingelheim Kg	Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
SE9302777D0 (sv) *	1993-08-27	1993-08-27	Astra Ab	Process for conditioning substances
US5874063A (en) *	1991-04-11	1999-02-23	Astra Aktiebolag	Pharmaceutical formulation
JP3908269B2 (ja) *	1991-12-18	2007-04-25	スリーエムカンパニー	懸濁エアゾール製剤
ATE177941T1 (de) *	1992-12-09	1999-04-15	Boehringer Ingelheim Pharma	Stabilisierte medizinische aerosollösungen
GB9404945D0 (en)	1994-03-15	1994-04-27	Glaxo Group Ltd	Pharmaceutical composition
GB9426252D0 (en)	1994-12-24	1995-02-22	Glaxo Group Ltd	Pharmaceutical composition
DE19528145A1 (de) *	1995-08-01	1997-02-06	Boehringer Ingelheim Kg	Neue Arzneimittel und ihre Verwendung
US5824669A (en) *	1996-03-22	1998-10-20	Nitromed, Inc.	Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
SE9603669D0 (sv) *	1996-10-08	1996-10-08	Astra Ab	New combination
DE19653969A1 (de) *	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US6254882B1 (en) *	1997-09-16	2001-07-03	Sepracor Inc.	Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
GB9807232D0 (en)	1998-04-03	1998-06-03	Univ Cardiff	Aerosol composition
ES2234266T3 (es) *	1998-07-24	2005-06-16	Jago Research Ag	Formulaciones medicas para aerosoles.
JP4672143B2 (ja) *	1998-08-04	2011-04-20	ヤゴテックアーゲー	医薬用エーロゾル製剤
DE19847968A1 (de) *	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
DE19847969A1 (de) *	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Lagerfähig flüssige Formulierung mit Formoterol
DE19847970A1 (de) *	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Lagerfähige Wirkstoff-Formulierung
GB9902689D0 (en) *	1999-02-08	1999-03-31	Novartis Ag	Organic compounds
DE19921693A1 (de) *	1999-05-12	2000-11-16	Boehringer Ingelheim Pharma	Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika

1999
- 1999-05-12 DE DE19921693A patent/DE19921693A1/de not_active Ceased
2000
- 2000-03-05 UA UA2001128535A patent/UA74547C2/uk unknown
- 2000-05-02 SA SA00210064A patent/SA00210064B1/ar unknown
- 2000-05-03 RS RSP-2009/0083A patent/RS20090083A/sr unknown
- 2000-05-03 PL PL352131A patent/PL199442B1/pl unknown
- 2000-05-03 SG SG2010018414A patent/SG179293A1/en unknown
- 2000-05-03 EP EP10183425A patent/EP2269648A3/fr not_active Withdrawn
- 2000-05-03 CN CNB008073562A patent/CN1250290C/zh not_active Expired - Fee Related
- 2000-05-03 JP JP2000617928A patent/JP4612956B2/ja not_active Expired - Lifetime
- 2000-05-03 TR TR2009/01979T patent/TR200901979T2/xx unknown
- 2000-05-03 EP EP00929478A patent/EP1178832B1/fr not_active Expired - Lifetime
- 2000-05-03 EP EP10183369A patent/EP2269647A3/fr not_active Withdrawn
- 2000-05-03 MX MXPA01011400A patent/MXPA01011400A/es active IP Right Grant
- 2000-05-03 ME MEP-366/08A patent/MEP36608A/xx unknown
- 2000-05-03 AU AU47545/00A patent/AU775588B2/en not_active Ceased
- 2000-05-03 SG SG200307862-3A patent/SG158731A1/en unknown
- 2000-05-03 EE EEP201000020A patent/EE201000020A/xx unknown
- 2000-05-03 CN CNA2006100045262A patent/CN1839833A/zh active Pending
- 2000-05-03 WO PCT/EP2000/003943 patent/WO2000069468A1/fr not_active Ceased
- 2000-05-03 EP EP03008310A patent/EP1327452A3/fr not_active Ceased
- 2000-05-03 EE EEP201000018A patent/EE201000018A/xx unknown
- 2000-05-03 IL IL14611900A patent/IL146119A0/xx active IP Right Grant
- 2000-05-03 EE EEP200100594A patent/EE05193B1/xx not_active IP Right Cessation
- 2000-05-03 BR BR0010498-1A patent/BR0010498A/pt not_active Application Discontinuation
- 2000-05-03 SG SG2010018422A patent/SG178626A1/en unknown
- 2000-05-03 DK DK00929478T patent/DK1178832T3/da active
- 2000-05-03 SI SI200030181T patent/SI1178832T1/xx unknown
- 2000-05-03 SK SK1637-2001A patent/SK287072B6/sk not_active IP Right Cessation
- 2000-05-03 PT PT00929478T patent/PT1178832E/pt unknown
- 2000-05-03 EE EEP201000019A patent/EE05677B1/xx not_active IP Right Cessation
- 2000-05-03 RS YU71901A patent/RS50269B/sr unknown
- 2000-05-03 ES ES00929478T patent/ES2203470T3/es not_active Expired - Lifetime
- 2000-05-03 TR TR2001/03233T patent/TR200103233T2/xx unknown
- 2000-05-03 NZ NZ515596A patent/NZ515596A/en not_active IP Right Cessation
- 2000-05-03 EA EA200101156A patent/EA004657B1/ru not_active IP Right Cessation
- 2000-05-03 HK HK02104960.6A patent/HK1043064B/zh not_active IP Right Cessation
- 2000-05-03 AT AT00929478T patent/ATE245976T1/de active
- 2000-05-03 EP EP10180233A patent/EP2266621A3/fr not_active Withdrawn
- 2000-05-03 KR KR1020017014380A patent/KR100841909B1/ko not_active Expired - Fee Related
- 2000-05-03 HR HR20010828A patent/HRP20010828A2/hr not_active IP Right Cessation
- 2000-05-03 CZ CZ20014055A patent/CZ302328B6/cs not_active IP Right Cessation
- 2000-05-03 KR KR1020077009915A patent/KR100962059B1/ko not_active Expired - Fee Related
- 2000-05-03 DE DE50003116T patent/DE50003116D1/de not_active Expired - Lifetime
- 2000-05-03 EP EP05008960A patent/EP1570861A3/fr not_active Withdrawn
- 2000-05-03 HU HU0201103A patent/HUP0201103A3/hu not_active Application Discontinuation
- 2000-05-03 EP EP10183392A patent/EP2266620A3/fr not_active Withdrawn
- 2000-05-03 SG SG2010027928A patent/SG175465A1/en unknown
- 2000-05-03 CA CA002368583A patent/CA2368583C/fr not_active Expired - Fee Related
- 2000-05-03 PL PL383340A patent/PL206146B1/pl unknown
- 2000-05-09 TW TW089108828A patent/TWI272106B/zh not_active IP Right Cessation
- 2000-05-09 US US09/568,880 patent/US6455524B1/en not_active Expired - Lifetime
- 2000-05-09 TW TW093125578A patent/TW200505483A/zh unknown
- 2000-05-10 PE PE2000000437A patent/PE20010133A1/es not_active Application Discontinuation
- 2000-05-10 MY MYPI20002026A patent/MY129512A/en unknown
- 2000-05-10 UY UY26139A patent/UY26139A1/es not_active Application Discontinuation
- 2000-05-10 MY MYPI20045408A patent/MY134222A/en unknown
- 2000-05-11 CO CO00034118A patent/CO5140068A1/es unknown
- 2000-05-12 AR ARP000102288A patent/AR023972A1/es not_active Application Discontinuation
- 2000-10-24 US US09/695,581 patent/US6433027B1/en not_active Expired - Lifetime
2001
- 2001-10-22 IL IL146119A patent/IL146119A/en not_active IP Right Cessation
- 2001-10-30 ZA ZA200108942A patent/ZA200108942B/en unknown
- 2001-11-02 NO NO20015359A patent/NO328423B1/no not_active IP Right Cessation
- 2001-11-09 BG BG106095A patent/BG65189B1/bg unknown
2002
- 2002-02-14 US US10/075,687 patent/US6630466B2/en not_active Expired - Lifetime
2005
- 2005-12-20 IL IL172695A patent/IL172695A/en not_active IP Right Cessation
2006
- 2006-04-03 JP JP2006102070A patent/JP2006188534A/ja active Pending
2009
- 2009-12-03 NO NO20093464A patent/NO20093464L/no not_active Application Discontinuation
2010
- 2010-11-02 JP JP2010246159A patent/JP2011021037A/ja active Pending
- 2010-11-02 JP JP2010246160A patent/JP2011021038A/ja active Pending
- 2010-11-02 JP JP2010246158A patent/JP2011021036A/ja active Pending

Also Published As

Publication number	Publication date
KR20070050507A (ko)	2007-05-15
TWI272106B (en)	2007-02-01
SG175465A1 (en)	2011-11-28
DE19921693A1 (de)	2000-11-16
NO20093464L (no)	2001-11-02
SK16372001A3 (sk)	2002-03-05
EP1327452A3 (fr)	2004-01-21
IL146119A0 (en)	2002-07-25
WO2000069468A1 (fr)	2000-11-23
CZ20014055A3 (cs)	2002-02-13
IL172695A (en)	2011-07-31
EE201000020A (et)	2010-04-15
CN1350465A (zh)	2002-05-22
HUP0201103A2 (hu)	2002-09-28
EP2269648A2 (fr)	2011-01-05
CA2368583C (fr)	2010-01-05
EP1178832B1 (fr)	2003-07-30
EP2269647A3 (fr)	2012-04-18
US20020115681A1 (en)	2002-08-22
BG65189B1 (bg)	2007-06-29
YU71901A (sh)	2005-07-19
EE201000018A (et)	2010-04-15
KR100841909B1 (ko)	2008-06-30
HRP20010828B1 (fr)	2013-01-31
CA2368583A1 (fr)	2000-11-23
ZA200108942B (en)	2002-08-26
EP2266621A2 (fr)	2010-12-29
PL206146B1 (pl)	2010-07-30
BR0010498A (pt)	2002-02-26
IL146119A (en)	2006-08-01
JP4612956B2 (ja)	2011-01-12
US6630466B2 (en)	2003-10-07
EP2266621A3 (fr)	2013-01-23
CZ302328B6 (cs)	2011-03-16
MY129512A (en)	2007-04-30
HK1043064A1 (en)	2002-09-06
HUP0201103A3 (en)	2008-10-28
NO20015359D0 (no)	2001-11-02
NO20015359L (no)	2001-11-02
PL199442B1 (pl)	2008-09-30
AU4754500A (en)	2000-12-05
CN1839833A (zh)	2006-10-04
EE201000019A (et)	2010-04-15
MY134222A (en)	2007-11-30
PL352131A1 (en)	2003-07-28
CN1250290C (zh)	2006-04-12
EP1327452A2 (fr)	2003-07-16
EE05193B1 (et)	2009-08-17
EP2266620A2 (fr)	2010-12-29
DK1178832T3 (da)	2003-11-03
NO328423B1 (no)	2010-02-15
EA004657B1 (ru)	2004-06-24
ES2203470T3 (es)	2004-04-16
JP2011021036A (ja)	2011-02-03
EP1570861A2 (fr)	2005-09-07
UY26139A1 (es)	2000-12-29
SK287072B6 (sk)	2009-11-05
EP2269648A3 (fr)	2012-04-18
TR200901979T2 (tr)	2009-05-21
US6433027B1 (en)	2002-08-13
RS50269B (sr)	2009-07-15
SG179293A1 (en)	2012-04-27
JP2011021037A (ja)	2011-02-03
TR200103233T2 (tr)	2002-04-22
HRP20010828A2 (en)	2003-02-28
EA200101156A1 (ru)	2002-06-27
ATE245976T1 (de)	2003-08-15
EP1178832A1 (fr)	2002-02-13
JP2002544239A (ja)	2002-12-24
JP2011021038A (ja)	2011-02-03
EP2269647A2 (fr)	2011-01-05
CO5140068A1 (es)	2002-03-22
KR100962059B1 (ko)	2010-06-10
IL172695A0 (en)	2006-04-10
BG106095A (bg)	2002-06-28
SG178626A1 (en)	2012-03-29
DE50003116D1 (de)	2003-09-04
TW200505483A (en)	2005-02-16
MEP36608A (en)	2011-02-10
NZ515596A (en)	2003-10-31
SG158731A1 (en)	2010-02-26
JP2006188534A (ja)	2006-07-20
AR023972A1 (es)	2002-09-04
RS20090083A (sr)	2009-07-15
HK1043064B (zh)	2006-08-18
EP2266620A3 (fr)	2012-04-18
EE05677B1 (et)	2013-10-15
KR20020001876A (ko)	2002-01-09
MXPA01011400A (es)	2002-06-04
AU775588B2 (en)	2004-08-05
EP1570861A3 (fr)	2010-12-29
PE20010133A1 (es)	2001-03-02
SA00210064B1 (ar)	2006-08-12
PT1178832E (pt)	2003-12-31
US6455524B1 (en)	2002-09-24
SI1178832T1 (sl)	2003-12-31
EE200100594A (et)	2003-02-17

Publication	Publication Date	Title
UA74547C2 (en)	2006-01-16	Pharmaceutical composition based on anticholinergic compounds and beta-mimetics and method for its production
US9446054B2 (en)	2016-09-20	Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids
US20040002548A1 (en)	2004-01-01	Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20100197719A1 (en)	2010-08-05	Medicament compositions containing anticholinergically-effective compounds and betamimetics
CA2459493C (fr)	2011-08-02	Nouveaux composes pharmaceutiques d'inhalation
HK1096599A (en)	2007-06-08	Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics